Tue, 03 Jul 2018 12:39:49 GMT
Australia's FIRB grants approval for Sirtex's Chinese buyout
Sirtex Medical, the liver cancer treatment producer, has been granted an approval by the Australian Foreign Investment Review Board doe its $1.4B buyout by the Chinese consortium.